Correlation of MRI-Derived Apparent Diffusion Coefficient (ADC) Values With Gleason Scores in Prostate Cancer and

Victoria Y Bird1,2, Krystina Masihy1, Juan Varela3

  • 1Urology, National Medical Association and Research Group, Gainesville, USA.

Cureus
|April 17, 2026
PubMed
Abstract

Insights

Apparent diffusion coefficient (ADC) values from MRI show a significant inverse correlation with prostate cancer Gleason scores. Lower ADC values indicate more aggressive tumors, offering a potential objective biomarker for clinical use.

Area of Science:

  • Radiology and Oncology
  • Biomedical Imaging
  • Prostate Cancer Research

Background:

  • Characterizing prostate cancer (PCa) aggressiveness is challenging.
  • Multiparametric MRI (mpMRI) and PI-RADS scoring have limitations due to inter-reader variability.
  • Apparent diffusion coefficient (ADC) values from diffusion-weighted imaging (DWI) offer a potential objective biomarker for tumor severity.

Purpose of the Study:

  • To investigate the correlation between ADC values and Gleason scores in PCa.
  • To assess the potential of ADC as a non-invasive biomarker for PCa aggressiveness.

Main Methods:

  • Retrospective analysis of 181 PCa lesions from 101 patients.
  • Recorded minimum ADC (ADCmin) values and correlated them with Gleason scores (3+3, 3+4, 4+3, ≥4+4).
  • Statistical analysis using Welch's ANOVA and Games-Howell post hoc tests.

Main Results:

  • Mean ADC values progressively decreased with increasing Gleason scores.
  • Significant differences in ADC values were found across Gleason categories (p < 0.001).
  • Specifically, higher-risk Gleason categories (4+3 and ≥4+4) had significantly lower ADC values compared to lower-risk categories.

Conclusions:

  • MRI-derived ADC values inversely correlate with PCa Gleason scores.
  • ADC values show potential as a non-invasive biomarker for PCa aggressiveness.
  • Integrating ADC into clinical workflows may improve biopsy targeting, risk stratification, and treatment planning.